He aha ke koho: Mexidol a Mildronate paha?

Pin
Send
Share
Send

ʻO nā haʻalulu o ke kahe o ke koko o ka lolo, ka hopena maikaʻiʻole o nā toxins a me kahi hoʻohaʻahaʻa i ke kani vascular e alakaʻi i ka hōʻike o nā pilikia neurological, cardiological a me nā maʻi ʻē aʻe. I mea e pale ai i ka hoʻomohala ʻana o ka hypoxia a me ka make o nā kuleana o ka lolo, ua kuhikuhi ʻia nā mea maʻi i nā antioxidants, metabolics, antihypoxants, nootropics a me nā lāʻau lapaʻau neurotropic.

Aia i ka wahi o ka lesion, ma ka mālama ʻana i nā maʻi ischemic a me nā pathological neurological, ua hoʻohana ʻia nā ʻoihana e like me Mildronate a me Mexidol.

ʻO nā hiʻohiʻona maʻamau o nā lāʻau

Ua kuhikuhi ʻia aku ʻo Mexidol a me Mildronate no:

  • hoʻomaʻamaʻa i ka metabolism;
  • hoʻoulu o ke kahe koko i loko o nā moku o ka lolo;
  • hoʻonui i ke kū'ē i ke kino kino a me ke noʻonoʻo.

I ka mālamaʻana i nā maʻi ischemic a me nā pathologies neurological, ʻo Mildronate a me Mexidol e hoʻohana ʻia.

ʻO nā hōʻailona ʻē aʻe no ka hoʻohana kālā ʻana ma muli o ka loaʻa ʻana o nā hana a nā hana ikaika.

Mexidol

ʻO ke ʻano hana nui o Mexidol ʻo ka ethylmethylhydroxypyridine succinate. ʻO kēia kinona he mea hānai o ka acid succinic, kahi e hui pū ai i nā waiwai o kahi pale membrane, antioxidant a me ka mea hoʻokalakupua.

Hoʻokomo ka paʻakai waikawa e like me ka hoʻōla o nā huela momona, me ka hoʻohaʻahaʻa i ka pono o ke oxygen i nā kopa o ka lolo a hoʻonui i ko lākou kū i ka hypoxia. Hoʻolako ʻo Mexidol i ka hana ikaika o ka mitochondria a hoʻopaʻa i ke kiʻekiʻe o nā pūhui macroergic (ATP, etc.).

Hoʻonohonoho ka Mexidol i ka syntacellular synthes o nā nucleic acid a me ka hoʻihoʻi hou ʻana o nā membranes, hana i ka oxidation o glucose.

Hoʻonui ka lāʻau lāʻau i ka syntacellular synthes o nā nucleic acid a me ka hoʻihoʻi ʻana o nā membran cell, hana i ka oxidation glucose a hoʻomaikaʻi i ka hoʻoiho ʻana i ka synaptic ma waena o nā papa hana o ka lolo. ʻO ka hopena maikaʻi i ka hopena o ka rheological o ke koko a me ka pae o nā lipoproteins haʻahaʻa haʻahaʻa hiki ke hoʻemi i ka wahi o ka pōʻino i hiki ʻole i ka ischemia a pale i ka stenosis vascular i ka wā e hiki mai ana.

Hoʻohana ka hoʻohana ʻana o Mexidol no ka haʻalele i ka hoʻohaʻahaʻa i ka mea maʻi a hōʻemi i nā mea makemake i ka waiʻona.

Hōʻike ʻia ke kumu o ka lāʻau lapaʻau no nā ala holoholo penei:

  • encephalopathy o ka ʻokiʻoki, post-traumatic a me nā genesis ʻē aʻe, me ka hoʻohui pū hele pū me nā hana hoʻomāinoino;
  • vegetst-vascular dystonia, asthenia;
  • nā hopena o nā ulia cerebrovascular, TIA, nā maʻi ʻeha o ka traumatic;
  • ka nānāʻana o ka mālamaʻana o ka etiology o atherosclerotic (me ke ʻano o ka palaka maʻalahi);
  • IHD (ma ke ʻano he papa kuhikuhi holoʻokoʻa);
  • nā hopohopo pilikia me nā maʻi neurosis a me nā maʻi like-me-maʻi;
  • ka hoʻomoʻa me nā lāʻau antipsychotic, hoʻihoʻi i nā hōʻailona ma ka hilinaʻi i ka waiʻona (me ka nui o nā ʻano lāʻau vegetative-vascular a me ka maʻi neurosis);
  • ke kaumaha, ke kaumaha kino kaumaha (hoʻonui i ke kū'ē i ke kaumaha hypoxia a pale i ka hoʻomohala ʻana o nā maʻi ʻōnaehana).

Loaʻa ka lāʻau lapaʻau i ke ʻano o nā papa a me kahi hopena no ka infusion.

Ua kuhikuhi ʻia ʻo Mexidol no nā maʻi cerebrovascular, TIA, a me nā hōʻeha o ka lolo.
Hoʻohana ʻia ʻo Mexidol e mālama i nā pōpilikia o nā hopohopo i nā maʻi like me ka maʻi neurosis.
ʻO ka hoʻoneʻe ʻana i ka maʻi palaka me kahi hoʻonaʻauao mea hōʻailona kahi hōʻailona no ka hoʻohana ʻana o Mexidol.

ʻO nā hoʻohālikelike i ka hoʻohana ʻana iā Mexidol:

  • ka naʻau o kēlā me kēia mea no ka kōlea succinic;
  • ka huʻi o ka huehue a me ka hana ate;
  • lactation
  • hapai
  • nā makahiki o nā keiki.

Mililiana

ʻO ka mea waiwai a Mildronate he meldonium. ʻO ka hana nui o kēia māhele, a me kona kaila mea kikoʻī (gamma-butyrobetaine), aia i kēlā me kēia sela o ke kino o ke kanaka, ʻo ke kaupalena ʻana o ke aʻa o ka carnitine. Me ka hoʻohaʻahaʻa ʻana i ka hana carnitine, ʻoi aku ka nui o ka lawe ʻana i nā momona momona i loko o nā pūpuna, a me nā kumu kumu nui o ka ikehu o nā kino o nā ʻōpū o ke kino (ATP) e hana nui ʻia ma muli o ka glucose, ka hoʻomehana ʻana o ka mea i koi ai ka emi o ka oxygen a ʻaʻole waiho i ka nui o nā huahana hoʻōlaʻi o nā meaʻala.

Ke hoʻololi nei i ke ʻano o nā kaʻina metabolic e hōʻemi ana i ka koi o ka oxygen i nā kiko, hoʻoneʻe i ka hypoxia, a pale i ka hōʻeha ʻana o nā pūpuna ma o nā mea ʻino o nā hopena metabolic.

Kahi ka analogue o gamma-butyrobetaine a me nā waiwai vasodilating (vasodilating), e kōkua ana i ka hoʻomaikaʻi ʻana i ke kahe koko, e hoʻolohi i ka hoʻomohala ʻana i nā pūnaewele necrosis i ka wā hōʻeha o ka naʻau a me ka ischemic stroke. ʻO ka hoʻihoʻi hou ʻana i ke koko i ke aloha i nā ʻā ischemic hōʻemi i ka hōʻemi o ka hoʻopilikia trophic, hōʻemi i ka nui o ka maʻi ʻeha, hoʻonui i ka hoʻomanawanui a me ka hana.

Hoʻomaʻawale ʻo Mildronate i ka koi o ka oxygen oxygen ma o ka hoʻemi ʻana i ka hypoxia a pale i nā hōʻino ʻona mai nā toxins.

Hoʻohana ʻia ka hoʻohana ʻana o ka meldonium no ka hoʻihoʻi ʻana i nā hōʻailona hoʻohiki: ʻo ka lāʻau lapaʻau e hōʻemi i nā hōʻailona o ka hoʻomoʻokiʻoki, keʻakeʻa i nā hana hana o ke ʻano kikowaena kūloko a hoʻomaʻamaʻa i nā hana hoʻihoʻi i ka mālama ʻana i ka palaka hoʻomāinoino.

Ke hōʻike nei ke ʻano o ka hoʻohana ʻana iā Mildronate i kēia ala:

  • maʻi maʻi coronary, ukali me nā umauma o ka umauma ʻeha;
  • myocardial infarction;
  • hōʻino ka mea lahilahi i ka umauma o ka puʻuwai a me nā hemahema;
  • nā neʻe o ka lolo (cerebral infarction, pre-stroke stroke);
  • thrombosis o na ʻano ʻano like ʻole;
  • kahe ʻana i ka ʻōpū a me ka retina, pani ʻia o ka veinal retinal nui a me kāna mau lālā, retinopathy;
  • encircal encephalopathy, neuropathy a me nā palaka maʻi maʻi ʻē aʻe, loaʻa ka momona wikiwiki i ke ʻano type type 2;
  • haʻalele kīwaha;
  • ka hana haʻahaʻa;
  • ka kaumaha, ke kino kino.

Hoʻokahi mau haʻawina e hōʻike ana i ka hopena o Mildronate i ka mālama paʻakikī ʻana o ka maʻi pulmonary obstrate maʻiʻa.

Wahi i nā hōʻailona, ​​hoʻohana ʻia kekahi o ʻekolu ʻano hoʻokuʻu o ka lāʻau lapaʻau.

  • nā lāloʻi;
  • kaʻaila;
  • iaoea no ka parabulbar (intraocular) a me ka hoʻokele intravenous.
Hoʻohana ʻia ka Mildronate no ka maʻi naʻau coronary, i kaʻaʻi pū ʻia e nā hōʻeha o ka umauma umauma.
ʻO ka maʻi o ke kaʻo o ka lolo (ka cerebral infarction, pre-stroke preval) kahi hōʻailona no ka lawe ʻana iā Mildronate.
Hoʻomaopopo ʻia ka hoʻohana ʻana o ka meldonium no ka hoʻihoʻi ʻana i nā hōʻailona, ​​kahi lāʻau lapaʻau e hōʻemi i nā mea hōʻike o ka hoʻāliʻi.

Nā maʻi hoʻohālikelike me Mildronate:

  • ka paʻakikī o kekahi kanaka i nā mea o ka lāʻau lapaʻau;
  • pākaha intracranial kiʻekiʻe (me nā maʻi a me ka ulu ʻana o ka puka i waho nui);
  • hapai
  • lactation
  • nā makahiki o nā keiki.

Me nā pilikia nui o ka pūpū a me ka puʻuwai, e pono ke hoʻokō ʻia o ka lāʻau me ka mālama ʻana.

ʻO ka hoʻohālikelike o Mexidol a me Mildronate

Hoʻohana ʻia ka Mildronate a me Mexidol no nā hōʻailona like a loaʻa iā ia nā hopena antihypoxic, kahi e hoʻoholo ai i ko lākou hopena i ka ischemia o nā kahawai o ka lolo. ʻOiai ke ʻano like, ʻaʻole like nā lāʻau lapaʻau i nā ʻāpana like a ʻokoʻa ʻole i nā ʻano hana like ʻole.

Hoʻohālike

ʻO nā lāʻau ʻelua ke hoʻemi i ka ʻelee o ka oxygen o nā ʻōpū a me nā puʻuwai naʻau o ka naʻau ma ke kāohi ʻana i ka hopena peroxide (ma ka hihia o Mexico. ʻAe kēia iā ʻoe e hōʻemi i ka wahi o nā nekrosis i ka hōʻeha ʻana a me ka hoʻouka puʻuwai, a me ka hoʻonui ʻana i ka hoʻomanawanui i nā kaumaha kaumaha.

ʻO ka hoʻomaikaʻi ʻana i ke kahe koko i ka wā o ka maʻi me ka Mexidol a i Mildronate i loaʻa kahi hopena maikaʻi loa i ka poʻe maʻi i hōʻeha i kahi maʻi a i ʻole ka maʻi i ka haʻalele mai.

Hoʻonui ka maikaʻi o ka lāʻau lapaʻau i ka hopena hopena o ka hopena. Me ka ischemic stroke, ʻo nā hōʻailona o ka maʻi vestibulo-ataxic, arrhythmias, hoʻihoʻi i nā hōʻailona a me nā ala ʻē aʻe, hiki ke lawe ʻia ʻo Mildronate a me Mexidol i ka manawa like.

Controllicated ka Mildronate a me Mexidol i ka wā hāpai a me ka lactation.

ʻOkoʻa ka ʻokoʻa

ʻO ka ʻokoʻa ma waena o nā lāʻau lapaʻau ʻelua i nā mea ʻenehana a me ke kikoʻī o ka hoʻolaha. ʻO Mexicoidol kahi membrane-stabilizing, nootropic, cerebroprotective, antioxidant a nāwaliwali anxiolytic hopena, a ʻo Mildronate he hopena angio- a me ka cardioprotective.

Me ka lapaʻau Mexidol, ka hopena o:

  • ka malo maloʻo
  • ninini
  • kūlohelohe;
  • hiamoe.

Nā hopena ʻokoʻa o Mildronate i:

  • ʻumiina
  • hoʻonui ulu naʻau;
  • loli;
  • huhū.

I nā hihia pinepine, nāwaliwali, nā hopena alerine, a me ka hoʻonui ʻana o ka neʻe ʻana o nā eosinophils e nānā ʻia.

Hoʻokomo ʻia nā lāʻau ʻelua i ka wā kamaliʻi.

ʻOi ka uku

ʻO ke kumu kūʻai o Mexidol mai 274 mau rubles no 30 mau papa (dosage - 125 mg) a mai 1423 mau rubles no 20 ampoules o 5 ml (dosage - 50 mg / ml).

Hoʻomaka ke kumukūʻai o Mildronate mai 255 mau rubles no ka 40 mau kōlena (dosage - 250 mg) a mai 355 mau rubles no 10 ampoules o 5 ml (dosage - 100 mg / ml).

Ke noʻonoʻo nei i ka dosis therapeutic i ʻōlelo ʻia (400-800 mg / lā no Mexidol a me 500-1000 mg / lā no Mildronate), maʻi meldonium me nā hōʻailona like e uku ʻia aku ka uku.

ʻO kaʻoi aku ka maikaʻi: Mexidol a Mildronate

ʻO ka maʻiʻo Mexidol he lāʻau nootropic a me antioxidant, kahi mea i kuhikuhi pinepine ʻia no nā pilikia o ke kolo o ke koko i ka lolo o ka lolo a me nā lesions atherosclerotic vascular. Ua loaʻa i ka Mildronate ka hopena nui ma nā kaʻina metabolic i loko o nā pūpū a me ka kūlana o ka papahana o cardiovascular.

ʻO ke koho o nā kālā he pono i ka kauka hele ʻana (neurologist, cardiologist, narcologist). I ke koho ʻana i ka lāʻau lapaʻau, mālama ʻo ia i nā hōʻike a me ka mōʻaukala o ka mea maʻi.

Mexidol: nā ʻōlelo aʻoaʻo no ka hoʻohana ʻana, nā hōʻike ʻana, ka loiloi o ke kauka
Ka hana o ka hana o ka lāʻau Mildronate
Mexidol: Hoʻomaka ʻo Brain

Hōʻike nā kauka i nā kauka

Poroshnichenko A.I., neurologist, Ryazan

He lāʻau lapaʻau kūpono a mika nō ʻo Mexidol o kahi mea hana home kūwaho, i kauoha ʻia no ka nui o nā pathological neurological. Uaʻike maikaʻi ʻia nā mea maʻi a hoʻonāukiuki i nā hopena ʻino.

ʻO ka pohō ʻole o ka lāʻau lapaʻau ʻo ka haʻahaʻa haʻahaʻa o kāna ʻano waha (mau papa). No ka wikiwiki o ka hopena, e lawe ʻia ʻo Mexidol i ka intravenously a i ʻole intramuscularly.

Mayakov A.I., narcologist, Kursk

Hoʻopau ana ʻo Mildronate i nā hōʻike maʻamau asthenic, hoʻopau i ka manawa hoʻoponopono hou no ka maʻi ʻalaka a hoʻoneʻe i nā hana trophic i loko o nā māla nerve peripheral i nā maʻi e like me ka maʻi maʻi. Loaʻa i ka lāʻau lapaʻa ka hopena antiarrhythmic a hōʻemi i ka lōʻihi o ka hana a kekahi mau lāʻau psychoactive.

ʻO ka Minus Mildronate nā hopena ʻalemi (nāwaliwali, maʻi pākē, nā loli i ke kaʻe o ke koko), akā naʻe, ʻokoʻa lākou.

I ka noʻonoʻo ʻana i ke ʻano loea i hōʻike ʻia, ʻo ke ʻano meldonium me nā hōʻailona like, e uku ʻia ke kumukūʻai.

ʻO nā loiloi maʻi maʻi e pili ana i ka Mexidol a me Mildronate

Ekaterina, 41 makahiki, Moscow

Ma hope o ka hōʻeha ʻana ma hope o ka pale (ʻo ka maʻi he hernia o ka spine cervical), puka maila nā ʻeha i loko o ka luakini a me ke kua o ke poʻo. Inu wau i nā mea hōʻeha wai i kekahi mau lā, a laila huli wau i kahi neurologist. Ua kuhikuhi ke kauka i kahi papa o 10 injections o Mexidol. Ma ka lā 4, ua loaʻa iaʻu ka hoʻomaikaʻi mua ʻana, ma ka lā 6, hele a pau ka ʻeha.

Ma hope o ka lapaʻau ʻana, ʻike ʻo ia ua hoʻomaka ʻo ia e hiamoe maikaʻi, pane iki me ka mālie a me ka hoʻohui ʻana i ke koʻikoʻi a me nā hakakā, a ʻoi hou ka wikiwiki. ʻAʻole wau i ʻike i nā hopena'ē aʻe, ua hauʻoli wau i ka lāʻau lapaʻau.

Maria, 33 makahiki, Tomsk

Ua hoʻopaʻa wau iā Mildronate no nā lā 10 ma ke noi ʻana o kekahi kauka. I ka wā mua, ʻike ʻole ʻia ka hopena, akā ma hope o ka papa holoʻokoʻa ua hoʻi hou ke kahe, ua kani ka leo, me ka uha a me ka ʻehaʻeha. I kēia manawa ua lilo wau i mea ikaika loa ma ka hana a hiki ke hele i ka manawa i kaʻu mau hana punahele.

ʻO nā hōʻeha kahi hana maikaʻi ʻole ia, akā he mea kupanaha ka hopena o lākou.

Pin
Send
Share
Send